Fulcrum Therapeutics, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:FULC) | MetaTrader

Open full chart

News

Fulcrum Therapeutics (FULC) Loses 51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

FULC Stock Crashes as Cancer Risk Forces Its Only Drug Program's End

Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns

FULC Stock Crashes After Hours: What Investors Need To Know - Fulcrum Therapeutics (NASDAQ:FULC)

After Plunging 21.5% in 4 Weeks, Here's Why the Trend Might Reverse for Fulcrum Therapeutics (FULC)

Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher

Fulcrum Therapeutics at Leerink Conference: Strategic Focus on Sickle Cell

Fulcrum Therapeutics stock may face pressure on Ipsen withdrawal, Stifel says

Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)

Fulcrum Therapeutics stock falls as sickle cell trial misses target

Leerink reiterates Fulcrum Therapeutics stock rating on SCD data

BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7